Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
CMHC
vs
S
Swiss Market Index
CMHC
Over the past 12 months, CMHC has underperformed Swiss Market Index, delivering a return of -16% compared to Swiss Market Index's +9% growth.
Stocks Performance
CMHC vs Swiss Market Index
Performance Gap
CMHC vs Swiss Market Index
Performance By Year
CMHC vs Swiss Market Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Cosmo Pharmaceuticals NV
Glance View
Cosmo Pharmaceuticals is a specialty drug company focused on digestive health and endoscopy. It develops medicines and medical products used to treat gastrointestinal conditions and to help doctors inspect and treat the colon and other parts of the digestive tract. Its products are aimed mainly at hospitals, gastroenterologists, and sometimes pharmacies, depending on the product and market. The company makes money by selling its own branded products and by licensing or partnering around medicines and device-related products in its field. In practice, that means it may earn revenue from product sales, supply agreements, and payments tied to commercial partnerships. This gives it a mix of direct sales and collaboration-based income. What makes Cosmo different is its tight focus on a narrow area of medicine rather than broad healthcare. It sits in the middle of the value chain: it develops or in-licenses products, works through regulators and clinical testing, and then sells them to doctors, hospitals, or larger drugmakers that help reach the market. That specialty focus makes it easier to build expertise in a few high-need treatment areas.
